참고문헌
- Bradley M, Zeytun A, Rafi-Janajreh A, et al (1998). Role of spontaneous and interleukin-2-induced natural killer cell activity in the cytotoxicity and rejection of Fas+ and Fas- tumor cells. Blood, 92, 4248-55.
- Chen R, Deng X, Wu H, et al (2014). Combined immunotherapy with dendritic cells and cytokine-induced killer cells for malignant tumors: a systematic review and meta-analysis. Int Immunopharmacol, 22, 451-64. https://doi.org/10.1016/j.intimp.2014.07.019
- Choudhury A, Palma M, Mellstedt H (2008). The future of cancer vaccines for non-small-cell lung cancer: ongoing trials. Clin Lung Cancer, 9, 37-44. https://doi.org/10.3816/CLC.2008.s.006
- Danielle D, Parker P, Fouladi R, et al (2003). The association between social support, intrusive thoughts, avoidance, and adjustment following an experimental cancer treatment. Psychooncology, 12, 453-62. https://doi.org/10.1002/pon.656
- Ferlay J, Soerjomataram I, Ervik M, et al (2013). GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC CancerBase No. 11 (Internet). Lyon, France: international agency for research on cancer; Available from: http://globocan.iarc.fr, accessed on day/month/year.
- Gao D, Li C, Xie X, et al (2014). Autologous tumor lysate-pulsed dendritic cell immunotherapy with cytokine-induced killer cells improves survival in gastric and colorectal cancer patients. PLoS One, 9, 93886. https://doi.org/10.1371/journal.pone.0093886
- Han RX, Liu X, Pan P, et al (2014). Effectiveness and safety of chemotherapy combined with dendritic cells co-cultured with cytokine-induced killer cells in the treatment of advanced non-small-cell lung cancer: a systematic review and meta-analysis. PLoS One, 9, 108958. https://doi.org/10.1371/journal.pone.0108958
- Heusel J, Wesselschmidt R, Shresta S, et al (1994). Cytotoxic lymphocytes require granzymeB for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell, 76, 977-87. https://doi.org/10.1016/0092-8674(94)90376-X
- Jin C, Li J, Wang Y, et al (2014). Impact of cellular immune function on prognosis of lung cancer patients after cytokine-induced killer cell therapy. Asian Pac J Cancer Prev, 15, 6009-14. https://doi.org/10.7314/APJCP.2014.15.15.6009
- Kagi D, Ledermann B, Burki K, et al (1994). Cytotoxicity mediated by T cells and natural killer cells is greatly impaired inperforin-deficient mice. Nature, 5, 31-7.
- Liu P, Chen L, Huang X (2009). The antitumor effects of CIK cells combined with docetaxel against drug-resistant lung adenocarcinoma cell line SPC-A1/DTX in vitro and in vivo. Cancer Biother Radiopharm, 24, 91-8. https://doi.org/10.1089/cbr.2008.0533
- Marten A, Ziske C, Schottker B, et al (2001). Interactions between dendritic cells and cytokine-induced killer cells lead to an activation of both populations. J Immunother, 24, 502-10. https://doi.org/10.1097/00002371-200111000-00007
- Ren J, Di L, Song G, et al (2013). Selections of appropriate regimen of high-dose chemotherapy combined with adoptive cellular therapy with dendritic and cytokine-induced killer cells improved progression-free and overall survival in patients with metastatic breast cancer: reargument of such contentious therapeutic preferences. Clin Transl Oncol, 15, 780-8. https://doi.org/10.1007/s12094-013-1001-9
- Schmidt-Wolf IG, Lefterova P, Johnston V, et al (1996). Sensitivity of multidrug-resistant tumor cell lines to immunologic effector cells. Cell Immunol, 169, 85-90. https://doi.org/10.1006/cimm.1996.0094
- Shi L, Zhou Q, Wu J, et al (2012). Efficacy of adjuvant immunotherapy with cytokine-induced killer cells in patients with locally advanced gastric cancer. Cancer Immunol Immunother, 61, 2251-9. https://doi.org/10.1007/s00262-012-1289-2
- Shi SB, Tang XY, Tian J, et al (2014). Efficacy of erlotinib plus dendritic cells and cytokine-induced killer cells in maintenance therapy of advanced non-small cell lung cancer. J Immunother, 37, 250-5. https://doi.org/10.1097/CJI.0000000000000015
- Song G, Wang X, Jia J, et al (2013). Elevated level of peripheral CD8(+)CD28(-) T lymphocytes are an independent predictor of progression-free survival in patients with metastatic breast cancer during the course of chemotherapy. Cancer Immunol Immunother, 62, 1123-30. https://doi.org/10.1007/s00262-013-1424-8
- Wang D, Zhang B, Gao H, et al (2014a). Clinical research of genetically modified dendritic cells in combination with cytokine-induced killer cell treatment in advanced renal cancer. BMC Cancer, 14, 251. https://doi.org/10.1186/1471-2407-14-251
- Wang ZX, Cao JX, Liu ZP, et al (2014b). Combination of chemotherapy and immunotherapy for colon cancer in China: a meta-analysis. World J Gastroenterol, 20, 1095-106. https://doi.org/10.3748/wjg.v20.i4.1095
- Wang ZX, Cao JX, Wang M, et al (2014c). Adoptive cellular immunotherapy for the treatment of patients with breast cancer: a meta-analysis. Cytotherapy, 16, 934-45. https://doi.org/10.1016/j.jcyt.2014.02.011
- Zhao Y, Song Y, Zhang H, et al (2014). Clinical analysis of patients suffering from advanced malignancy with survival time less than 3 months by DC-CIK cells. Cancer Res Prev Treat, 41, 397-400.
피인용 문헌
- Dual Functional Capability of Dendritic Cells – Cytokine-Induced Killer Cells in Improving Side Effects of Colorectal Cancer Therapy vol.8, pp.1663-9812, 2017, https://doi.org/10.3389/fphar.2017.00126
- Enhanced antitumor effects and improved immune status of dendritic cell and cytokine-induced killer cell infusion in advanced cancer patients vol.7, pp.5, 2017, https://doi.org/10.3892/mco.2017.1415
- Combination of DC/CIK adoptive T cell immunotherapy with chemotherapy in advanced non-small-cell lung cancer (NSCLC) patients: a prospective patients’ preference-based study (PPPS) pp.1699-3055, 2018, https://doi.org/10.1007/s12094-018-1968-3